[Focus] Sales policy of new Sanofi-Aventis company attracts keen interest

As Sanofi-Synthelabo and Aventis SA plans to create the world' third largest pharmaceutical company on August 20 after Sanofi increased an earlier hostile bid for Aventis, domestic drug wholesalers and pharmaceutical firms have been closely watching the movement of Sanofi Korea, notably on their sales policies.

The crucial point in question is whether Sanofi Korea, which has still refused to...